Search by Drug Name or NDC

    NDC 10135-0669-01 Senna S 50; 8.6 mg/1; mg/1 Details

    Senna S 50; 8.6 mg/1; mg/1

    Senna S is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Marlex Pharmaceuticals Inc. The primary component is DOCUSATE SODIUM; SENNOSIDES.

    Product Information

    NDC 10135-0669
    Product ID 10135-669_0a3528b3-fa64-c187-e063-6294a90a81dd
    Associated GPIs 46991002770320
    GCN Sequence Number 048044
    GCN Sequence Number Description sennosides/docusate sodium TABLET 8.6MG-50MG ORAL
    HIC3 D6S
    HIC3 Description LAXATIVES AND CATHARTICS
    GCN 13483
    HICL Sequence Number 021772
    HICL Sequence Number Description SENNOSIDES/DOCUSATE SODIUM
    Brand/Generic Generic
    Proprietary Name Senna S
    Proprietary Name Suffix n/a
    Non-Proprietary Name Docusate Sodium and Sennosides
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 50; 8.6
    Active Ingredient Units mg/1; mg/1
    Substance Name DOCUSATE SODIUM; SENNOSIDES
    Labeler Name Marlex Pharmaceuticals Inc
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M007
    Listing Certified Through 2024-12-31

    Package

    NDC 10135-0669-01 (10135066901)

    NDC Package Code 10135-669-01
    Billing NDC 10135066901
    Package 1 BOTTLE in 1 CARTON (10135-669-01) / 100 TABLET in 1 BOTTLE
    Marketing Start Date 2018-10-01
    NDC Exclude Flag N
    Pricing Information N/A